Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in the New York, NY, London, U.K and Carmel, IN. For more information, visit http://www.antidote.me.